How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-premature-ovulation-during-controlled-ovarian-stimulation.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of premature ovulation during controlled ovarian stimulation — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of premature ovulation during controlled ovarian stimulation (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of premature ovulation during controlled ovarian stimulation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cetrotide	CETRORELIX	Merck KGaA	Gonadotropin Releasing Hormone Receptor Antagonist	Gonadotropin-releasing hormone receptor	2000-01-01
Gynorest	DYDROGESTERONE	Solvay	dydrogesterone	Progesterone receptor	1982-01-01
Cetrotide	Cetrotide	Wolfson Medical Center		Gonadotropin-releasing hormone receptor, Lutropin-choriogonadotropic hormone receptor
Depo-Provera	medroxyprogesterone	Pfizer	Progestin	Progesterone receptor	1959-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-04-29 — Cetrotide · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck KGaA · 1 drug in Prevention of premature ovulation during controlled ovarian stimulation
Pfizer · 1 drug in Prevention of premature ovulation during controlled ovarian stimulation
Solvay · 1 drug in Prevention of premature ovulation during controlled ovarian stimulation
Wolfson Medical Center · 1 drug in Prevention of premature ovulation during controlled ovarian stimulation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of premature ovulation during controlled ovarian stimulation:

Cite this brief

Drug Landscape (2026). Prevention of premature ovulation during controlled ovarian stimulation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-premature-ovulation-during-controlled-ovarian-stimulation. Accessed 2026-06-10.

Prevention of premature ovulation during controlled ovarian stimulation full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing